Global Swine Flu Vaccine Supply, Demand and Key Producers, 2023-2029
Page: 96
Published Date: 23 Jan 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
The global Swine Flu Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Swine flu is infection of the respiratory system caused by influenza viruses. These viruses also infect the respiratory system of pigs causing barking cough, decrease in appetite, nasal secretions, and listless behavior. Influenza viruses can also be transmitted to humans. Swine flu viruses can induce genetic changes or mutations so that these are easily transmissible among humans.
This report studies the global Swine Flu Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Swine Flu Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Swine Flu Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Swine Flu Vaccine total production and demand, 2018-2029, (K Dose)
Global Swine Flu Vaccine total production value, 2018-2029, (USD Million)
Global Swine Flu Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Dose)
Global Swine Flu Vaccine consumption by region & country, CAGR, 2018-2029 & (K Dose)
U.S. VS China: Swine Flu Vaccine domestic production, consumption, key domestic manufacturers and share
Global Swine Flu Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Dose)
Global Swine Flu Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Dose)
Global Swine Flu Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Dose)
This reports profiles key players in the global Swine Flu Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, CSL Limited, Zydus Cadila, AstraZeneca, GlaxoSmithKline, Sanofi, Baxter and Sinovac Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Swine Flu Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Swine Flu Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Swine Flu Vaccine Market, Segmentation by Type
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Others
Global Swine Flu Vaccine Market, Segmentation by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Clinic And Vaccination Centers
Companies Profiled:
Novartis
CSL Limited
Zydus Cadila
AstraZeneca
GlaxoSmithKline
Sanofi
Baxter
Sinovac Biotech
Key Questions Answered
1. How big is the global Swine Flu Vaccine market?
2. What is the demand of the global Swine Flu Vaccine market?
3. What is the year over year growth of the global Swine Flu Vaccine market?
4. What is the production and production value of the global Swine Flu Vaccine market?
5. Who are the key producers in the global Swine Flu Vaccine market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Swine Flu Vaccine Introduction
1.2 World Swine Flu Vaccine Supply & Forecast
1.2.1 World Swine Flu Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Swine Flu Vaccine Production (2018-2029)
1.2.3 World Swine Flu Vaccine Pricing Trends (2018-2029)
1.3 World Swine Flu Vaccine Production by Region (Based on Production Site)
1.3.1 World Swine Flu Vaccine Production Value by Region (2018-2029)
1.3.2 World Swine Flu Vaccine Production by Region (2018-2029)
1.3.3 World Swine Flu Vaccine Average Price by Region (2018-2029)
1.3.4 North America Swine Flu Vaccine Production (2018-2029)
1.3.5 Europe Swine Flu Vaccine Production (2018-2029)
1.3.6 China Swine Flu Vaccine Production (2018-2029)
1.3.7 Japan Swine Flu Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Swine Flu Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Swine Flu Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 Demand Summary
2.1 World Swine Flu Vaccine Demand (2018-2029)
2.2 World Swine Flu Vaccine Consumption by Region
2.2.1 World Swine Flu Vaccine Consumption by Region (2018-2023)
2.2.2 World Swine Flu Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Swine Flu Vaccine Consumption (2018-2029)
2.4 China Swine Flu Vaccine Consumption (2018-2029)
2.5 Europe Swine Flu Vaccine Consumption (2018-2029)
2.6 Japan Swine Flu Vaccine Consumption (2018-2029)
2.7 South Korea Swine Flu Vaccine Consumption (2018-2029)
2.8 ASEAN Swine Flu Vaccine Consumption (2018-2029)
2.9 India Swine Flu Vaccine Consumption (2018-2029)
3 World Swine Flu Vaccine Manufacturers Competitive Analysis
3.1 World Swine Flu Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Swine Flu Vaccine Production by Manufacturer (2018-2023)
3.3 World Swine Flu Vaccine Average Price by Manufacturer (2018-2023)
3.4 Swine Flu Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Swine Flu Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Swine Flu Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Swine Flu Vaccine in 2022
3.6 Swine Flu Vaccine Market: Overall Company Footprint Analysis
3.6.1 Swine Flu Vaccine Market: Region Footprint
3.6.2 Swine Flu Vaccine Market: Company Product Type Footprint
3.6.3 Swine Flu Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Swine Flu Vaccine Production Value Comparison
4.1.1 United States VS China: Swine Flu Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Swine Flu Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Swine Flu Vaccine Production Comparison
4.2.1 United States VS China: Swine Flu Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Swine Flu Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Swine Flu Vaccine Consumption Comparison
4.3.1 United States VS China: Swine Flu Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Swine Flu Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Swine Flu Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Swine Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Swine Flu Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Swine Flu Vaccine Production (2018-2023)
4.5 China Based Swine Flu Vaccine Manufacturers and Market Share
4.5.1 China Based Swine Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Swine Flu Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Swine Flu Vaccine Production (2018-2023)
4.6 Rest of World Based Swine Flu Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Swine Flu Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Swine Flu Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Swine Flu Vaccine Production (2018-2023)
5 Market Analysis by Type
5.1 World Swine Flu Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Intradermal Vaccination
5.2.2 Intramuscular Vaccination
5.2.3 Subcutaneous Vaccination
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Swine Flu Vaccine Production by Type (2018-2029)
5.3.2 World Swine Flu Vaccine Production Value by Type (2018-2029)
5.3.3 World Swine Flu Vaccine Average Price by Type (2018-2029)
6 Market Analysis by Application
6.1 World Swine Flu Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.2.4 Clinic And Vaccination Centers
6.3 Market Segment by Application
6.3.1 World Swine Flu Vaccine Production by Application (2018-2029)
6.3.2 World Swine Flu Vaccine Production Value by Application (2018-2029)
6.3.3 World Swine Flu Vaccine Average Price by Application (2018-2029)
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Swine Flu Vaccine Product and Services
7.1.4 Novartis Swine Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 CSL Limited
7.2.1 CSL Limited Details
7.2.2 CSL Limited Major Business
7.2.3 CSL Limited Swine Flu Vaccine Product and Services
7.2.4 CSL Limited Swine Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 CSL Limited Recent Developments/Updates
7.2.6 CSL Limited Competitive Strengths & Weaknesses
7.3 Zydus Cadila
7.3.1 Zydus Cadila Details
7.3.2 Zydus Cadila Major Business
7.3.3 Zydus Cadila Swine Flu Vaccine Product and Services
7.3.4 Zydus Cadila Swine Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Zydus Cadila Recent Developments/Updates
7.3.6 Zydus Cadila Competitive Strengths & Weaknesses
7.4 AstraZeneca
7.4.1 AstraZeneca Details
7.4.2 AstraZeneca Major Business
7.4.3 AstraZeneca Swine Flu Vaccine Product and Services
7.4.4 AstraZeneca Swine Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 AstraZeneca Recent Developments/Updates
7.4.6 AstraZeneca Competitive Strengths & Weaknesses
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Details
7.5.2 GlaxoSmithKline Major Business
7.5.3 GlaxoSmithKline Swine Flu Vaccine Product and Services
7.5.4 GlaxoSmithKline Swine Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 GlaxoSmithKline Recent Developments/Updates
7.5.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.6 Sanofi
7.6.1 Sanofi Details
7.6.2 Sanofi Major Business
7.6.3 Sanofi Swine Flu Vaccine Product and Services
7.6.4 Sanofi Swine Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Sanofi Recent Developments/Updates
7.6.6 Sanofi Competitive Strengths & Weaknesses
7.7 Baxter
7.7.1 Baxter Details
7.7.2 Baxter Major Business
7.7.3 Baxter Swine Flu Vaccine Product and Services
7.7.4 Baxter Swine Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Baxter Recent Developments/Updates
7.7.6 Baxter Competitive Strengths & Weaknesses
7.8 Sinovac Biotech
7.8.1 Sinovac Biotech Details
7.8.2 Sinovac Biotech Major Business
7.8.3 Sinovac Biotech Swine Flu Vaccine Product and Services
7.8.4 Sinovac Biotech Swine Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sinovac Biotech Recent Developments/Updates
7.8.6 Sinovac Biotech Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Swine Flu Vaccine Industry Chain
8.2 Swine Flu Vaccine Upstream Analysis
8.2.1 Swine Flu Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Swine Flu Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Swine Flu Vaccine Production Mode
8.6 Swine Flu Vaccine Procurement Model
8.7 Swine Flu Vaccine Industry Sales Model and Sales Channels
8.7.1 Swine Flu Vaccine Sales Model
8.7.2 Swine Flu Vaccine Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Swine Flu Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Swine Flu Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Swine Flu Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Swine Flu Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Swine Flu Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Swine Flu Vaccine Production by Region (2018-2023) & (K Dose)
Table 7. World Swine Flu Vaccine Production by Region (2024-2029) & (K Dose)
Table 8. World Swine Flu Vaccine Production Market Share by Region (2018-2023)
Table 9. World Swine Flu Vaccine Production Market Share by Region (2024-2029)
Table 10. World Swine Flu Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 11. World Swine Flu Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 12. Swine Flu Vaccine Major Market Trends
Table 13. World Swine Flu Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Dose)
Table 14. World Swine Flu Vaccine Consumption by Region (2018-2023) & (K Dose)
Table 15. World Swine Flu Vaccine Consumption Forecast by Region (2024-2029) & (K Dose)
Table 16. World Swine Flu Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Swine Flu Vaccine Producers in 2022
Table 18. World Swine Flu Vaccine Production by Manufacturer (2018-2023) & (K Dose)
Table 19. Production Market Share of Key Swine Flu Vaccine Producers in 2022
Table 20. World Swine Flu Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 21. Global Swine Flu Vaccine Company Evaluation Quadrant
Table 22. World Swine Flu Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Swine Flu Vaccine Production Site of Key Manufacturer
Table 24. Swine Flu Vaccine Market: Company Product Type Footprint
Table 25. Swine Flu Vaccine Market: Company Product Application Footprint
Table 26. Swine Flu Vaccine Competitive Factors
Table 27. Swine Flu Vaccine New Entrant and Capacity Expansion Plans
Table 28. Swine Flu Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Swine Flu Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Swine Flu Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Dose)
Table 31. United States VS China Swine Flu Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Dose)
Table 32. United States Based Swine Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Swine Flu Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Swine Flu Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Swine Flu Vaccine Production (2018-2023) & (K Dose)
Table 36. United States Based Manufacturers Swine Flu Vaccine Production Market Share (2018-2023)
Table 37. China Based Swine Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Swine Flu Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Swine Flu Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Swine Flu Vaccine Production (2018-2023) & (K Dose)
Table 41. China Based Manufacturers Swine Flu Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Swine Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Swine Flu Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Swine Flu Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Swine Flu Vaccine Production (2018-2023) & (K Dose)
Table 46. Rest of World Based Manufacturers Swine Flu Vaccine Production Market Share (2018-2023)
Table 47. World Swine Flu Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Swine Flu Vaccine Production by Type (2018-2023) & (K Dose)
Table 49. World Swine Flu Vaccine Production by Type (2024-2029) & (K Dose)
Table 50. World Swine Flu Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Swine Flu Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Swine Flu Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 53. World Swine Flu Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 54. World Swine Flu Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Swine Flu Vaccine Production by Application (2018-2023) & (K Dose)
Table 56. World Swine Flu Vaccine Production by Application (2024-2029) & (K Dose)
Table 57. World Swine Flu Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Swine Flu Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Swine Flu Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 60. World Swine Flu Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Swine Flu Vaccine Product and Services
Table 64. Novartis Swine Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 68. CSL Limited Major Business
Table 69. CSL Limited Swine Flu Vaccine Product and Services
Table 70. CSL Limited Swine Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. CSL Limited Recent Developments/Updates
Table 72. CSL Limited Competitive Strengths & Weaknesses
Table 73. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 74. Zydus Cadila Major Business
Table 75. Zydus Cadila Swine Flu Vaccine Product and Services
Table 76. Zydus Cadila Swine Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Zydus Cadila Recent Developments/Updates
Table 78. Zydus Cadila Competitive Strengths & Weaknesses
Table 79. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 80. AstraZeneca Major Business
Table 81. AstraZeneca Swine Flu Vaccine Product and Services
Table 82. AstraZeneca Swine Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. AstraZeneca Recent Developments/Updates
Table 84. AstraZeneca Competitive Strengths & Weaknesses
Table 85. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 86. GlaxoSmithKline Major Business
Table 87. GlaxoSmithKline Swine Flu Vaccine Product and Services
Table 88. GlaxoSmithKline Swine Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 91. Sanofi Basic Information, Manufacturing Base and Competitors
Table 92. Sanofi Major Business
Table 93. Sanofi Swine Flu Vaccine Product and Services
Table 94. Sanofi Swine Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sanofi Recent Developments/Updates
Table 96. Sanofi Competitive Strengths & Weaknesses
Table 97. Baxter Basic Information, Manufacturing Base and Competitors
Table 98. Baxter Major Business
Table 99. Baxter Swine Flu Vaccine Product and Services
Table 100. Baxter Swine Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Baxter Recent Developments/Updates
Table 102. Sinovac Biotech Basic Information, Manufacturing Base and Competitors
Table 103. Sinovac Biotech Major Business
Table 104. Sinovac Biotech Swine Flu Vaccine Product and Services
Table 105. Sinovac Biotech Swine Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 106. Global Key Players of Swine Flu Vaccine Upstream (Raw Materials)
Table 107. Swine Flu Vaccine Typical Customers
Table 108. Swine Flu Vaccine Typical Distributors
List of Figure
Figure 1. Swine Flu Vaccine Picture
Figure 2. World Swine Flu Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Swine Flu Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Swine Flu Vaccine Production (2018-2029) & (K Dose)
Figure 5. World Swine Flu Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 6. World Swine Flu Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Swine Flu Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Swine Flu Vaccine Production (2018-2029) & (K Dose)
Figure 9. Europe Swine Flu Vaccine Production (2018-2029) & (K Dose)
Figure 10. China Swine Flu Vaccine Production (2018-2029) & (K Dose)
Figure 11. Japan Swine Flu Vaccine Production (2018-2029) & (K Dose)
Figure 12. Swine Flu Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Swine Flu Vaccine Consumption (2018-2029) & (K Dose)
Figure 15. World Swine Flu Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Swine Flu Vaccine Consumption (2018-2029) & (K Dose)
Figure 17. China Swine Flu Vaccine Consumption (2018-2029) & (K Dose)
Figure 18. Europe Swine Flu Vaccine Consumption (2018-2029) & (K Dose)
Figure 19. Japan Swine Flu Vaccine Consumption (2018-2029) & (K Dose)
Figure 20. South Korea Swine Flu Vaccine Consumption (2018-2029) & (K Dose)
Figure 21. ASEAN Swine Flu Vaccine Consumption (2018-2029) & (K Dose)
Figure 22. India Swine Flu Vaccine Consumption (2018-2029) & (K Dose)
Figure 23. Producer Shipments of Swine Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Swine Flu Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Swine Flu Vaccine Markets in 2022
Figure 26. United States VS China: Swine Flu Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Swine Flu Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Swine Flu Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Swine Flu Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Swine Flu Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Swine Flu Vaccine Production Market Share 2022
Figure 32. World Swine Flu Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Swine Flu Vaccine Production Value Market Share by Type in 2022
Figure 34. Intradermal Vaccination
Figure 35. Intramuscular Vaccination
Figure 36. Subcutaneous Vaccination
Figure 37. Others
Figure 38. World Swine Flu Vaccine Production Market Share by Type (2018-2029)
Figure 39. World Swine Flu Vaccine Production Value Market Share by Type (2018-2029)
Figure 40. World Swine Flu Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 41. World Swine Flu Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Swine Flu Vaccine Production Value Market Share by Application in 2022
Figure 43. Hospital Pharmacies
Figure 44. Retail Pharmacies
Figure 45. Online Pharmacies
Figure 46. Clinic And Vaccination Centers
Figure 47. World Swine Flu Vaccine Production Market Share by Application (2018-2029)
Figure 48. World Swine Flu Vaccine Production Value Market Share by Application (2018-2029)
Figure 49. World Swine Flu Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 50. Swine Flu Vaccine Industry Chain
Figure 51. Swine Flu Vaccine Procurement Model
Figure 52. Swine Flu Vaccine Sales Model
Figure 53. Swine Flu Vaccine Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novartis CSL Limited Zydus Cadila AstraZeneca GlaxoSmithKline Sanofi Baxter Sinovac Biotech
Related Reports
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>